Circulating Fatty Acids and Genetic Predisposition to Type 2 Diabetes: Gene-Nutrient Interaction Analysis

Pan Zhuang,Xiaohui Liu,Yin Li,Haoyu Li,Lange Zhang,Xuzhi Wan,Yuqi Wu,Yu Zhang,Jingjing Jiao

DOI: https://doi.org/10.2337/dc21-2048

2022-01-01

Diabetes Care

Abstract:OBJECTIVE: Toassess the relationship of circulating fatty acids (FAs) with risk of type 2diabetes (T2D) and potential interactions with genetic risk.RESEARCH DESIGN AND METHODS: 95,854participants with complete data on plasma FAs from the UK Biobank, wereenrolled between 2006 and 2010, and were followed up to the end of 2020. Plasmaconcentrations of saturated fatty acids (SFAs), monounsaturated fatty acids(MUFAs), and polyunsaturated fatty acids (PUFAs) were analyzed by ahigh-throughput NMR-based biomarker profiling platform. The genetic risk score(GRS) was calculated on the basis of 424 variants associated with T2D.Pathway-specific GRSs were calculated based on robust clusters of T2D loci.RESULTS: 3,052 T2D cases were documentedafter an average follow-up of 11.6 years. Plasma concentrations of SFAs andMUFAs were positively associated with T2D risk while plasma PUFAs wereinversely associated. After adjustment for major risk factors, HRs (95% CIs) ofT2D for 1 SD increment were 1.03 (1.02-1.04) for SFAs, 1.03 (1.02-1.05) forMUFAs, 0.62 (0.56-0.68) for PUFAs, 0.67 (0.61-0.73) for n-6 PUFAs, 0.90(0.85-0.95) for n-3 PUFAs, and 1.01 (0.98-1.04) for n-6/n-3 ratio. Plasma MUFAshad significant interactions with the overall GRS and GRSs for Proinsulin andLiver/Lipid clusters on T2D risk. The protective associations of n-3 PUFAs withT2D risk were weaker among individuals with higher Obesity GRS (Pinteraction=0.040) and Liver/Lipid GRS (P interaction=0.012). Additionally,increased plasma n-3 PUFA concentration was associated with more reductions inT2D risk among participants carrying more docosapentaenoic acid-associatedalleles (P interaction=0.007).CONCLUSIONS: Plasma concentrations of SFAs and MUFAs wereassociated with a higher T2D risk whereas plasma PUFAs and n-6 and n-3 PUFAswere related to a lower risk. Circulating MUFAs andn-3 PUFAs had significant interactions with genetic predisposition to T2D and FA-associated variants.